John M. Coffin

Active 1971–2024

129
Papers
26,592
Citations
97
h-index
127
i10-index

Citations

Citations per year for John M. Coffin1971: 2 citations1972: 3 citations1973: 4 citations1974: 5 citations1975: 1 citations1976: 1 citations1977: 8 citations1978: 5 citations1979: 6 citations1980: 19 citations1981: 21 citations1982: 37 citations1983: 34 citations1984: 24 citations1985: 10 citations1986: 31 citations1987: 52 citations1988: 51 citations1989: 51 citations1990: 70 citations1991: 85 citations1992: 92 citations1993: 76 citations1994: 96 citations1995: 73 citations1996: 125 citations1997: 121 citations1998: 99 citations1999: 60 citations2000: 77 citations2001: 63 citations2002: 51 citations2003: 53 citations2004: 106 citations2005: 105 citations2006: 131 citations2007: 129 citations2008: 171 citations2009: 212 citations2010: 227 citations2011: 317 citations2012: 316 citations2013: 288 citations2014: 280 citations2015: 258 citations2016: 258 citations2017: 211 citations2018: 246 citations2019: 723 citations2020: 742 citations2021: 614 citations2022: 379 citations2023: 318 citations2024: 434 citations2025: 186 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,241 citing papers, 43.9% of this breakdownUnited Kingdom: 516 citing papers, 7% of this breakdownFrance: 397 citing papers, 5.4% of this breakdownGermany: 343 citing papers, 4.6% of this breakdownCanada: 322 citing papers, 4.4% of this breakdownChina: 269 citing papers, 3.6% of this breakdownSpain: 193 citing papers, 2.6% of this breakdownItaly: 188 citing papers, 2.5% of this breakdownAustralia: 182 citing papers, 2.5% of this breakdownSwitzerland: 167 citing papers, 2.3% of this breakdownNetherlands: 159 citing papers, 2.2% of this breakdownJapan: 145 citing papers, 2% of this breakdown
0%43.9%Other 17%

Fields

  • Immunology and Microbiology47.6%
  • Medicine20.9%
  • Biochemistry, Genetics and Molecular Biology18.4%
  • Agricultural and Biological Sciences9.8%
  • Environmental Science0.9%
  • Neuroscience0.8%
  • Other1.6%

Topics

  • HIV Research and Treatment18%
  • HIV/AIDS drug development and treatment9.6%
  • HIV/AIDS Research and Interventions6.2%
  • Immune Cell Function and Interaction5.1%
  • CRISPR and Genetic Engineering3.8%
  • Chromosomal and Genetic Variations3.1%
  • Other54.2%

Coauthors

All papers

Open in search
  1. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells

    Authors: , , , , , , , , , , , - Science 2014 cited by 901

  2. Clonally expanded CD4 + T cells can produce infectious HIV-1 in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John W. Mellors, Frank Maldarelli - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 382

  3. Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

    Authors: , , , , , , , , , , , - PLoS Pathogens 2017 cited by 257

  4. Flexible Use of Nuclear Import Pathways by HIV-1

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2010 cited by 470

  5. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses

    Authors: , , , - Retrovirology 2011 cited by 460

  6. Discovery of unfixed endogenous retrovirus insertions in diverse human populations

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 289

  7. HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 cited by 149

  8. Effects of Retroviruses on Host Genome Function

    Authors: , - Annual Review of Genetics 2008 cited by 508

  9. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 646

  10. Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 179

  11. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues

    Authors: , , , - PLoS Biology 2022 cited by 65

  12. Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

    Authors: , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2017 cited by 221

  13. ICTV Virus Taxonomy Profile: Retroviridae 2021

    Authors: , , , , , , , , , - Journal of General Virology 2021 cited by 67

  14. HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy

    Authors: - Science 1995 cited by 1,993

  15. HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 122

  16. New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

    Authors: , , , , , , , , , , , - Journal of Clinical Microbiology 2003 cited by 611

  17. Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2008 cited by 593

  18. The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

    Authors: , , , , , , , , , , , , , , , , - PLoS Medicine 2010 cited by 307

  19. Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy

    Authors: , , , , , , , , , , , - PLoS Pathogens 2014 cited by 243

  20. Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy

    Authors: , , , , , , , , , , , , , - PLoS Pathogens 2021 cited by 67

  21. Quantification of HIV-1 latency reversal in resting CD4 + T cells from patients on suppressive antiretroviral therapy

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 243

  22. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy

    Authors: , , , , , , , , - Journal of Virology 2015 cited by 153

  23. Clones of infected cells arise early in HIV-infected individuals

    Authors: , , , , , , , , , , , , , , , - JCI Insight 2019 cited by 91

  24. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2007 cited by 513